BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 25408531)

  • 1. Prostate cancer risk prediction based on complete prostate cancer family history.
    Albright F; Stephenson RA; Agarwal N; Teerlink CC; Lowrance WT; Farnham JM; Albright LA
    Prostate; 2015 Mar; 75(4):390-8. PubMed ID: 25408531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-Based Relative Risks for Lung Cancer Based on Complete Family History of Lung Cancer.
    Cannon-Albright LA; Carr SR; Akerley W
    J Thorac Oncol; 2019 Jul; 14(7):1184-1191. PubMed ID: 31075544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based relative risks for specific family history constellations of breast cancer.
    Albright FS; Kohlmann W; Neumayer L; Buys SS; Matsen CB; Kaphingst KA; Cannon-Albright LA
    Cancer Causes Control; 2019 Jun; 30(6):581-590. PubMed ID: 31030355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative Risks for Lethal Prostate Cancer Based on Complete Family History of Prostate Cancer Death.
    Albright FS; Stephenson RA; Agarwal N; Cannon-Albright LA
    Prostate; 2017 Jan; 77(1):41-48. PubMed ID: 27527734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of pelvic organ prolapse treatment based on extended family history.
    Allen-Brady K; Norton PA; Hill AJ; Rowe K; Cannon-Albright LA
    Am J Obstet Gynecol; 2020 Jul; 223(1):105.e1-105.e8. PubMed ID: 31954153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative risk for Alzheimer disease based on complete family history.
    Cannon-Albright LA; Foster NL; Schliep K; Farnham JM; Teerlink CC; Kaddas H; Tschanz J; Corcoran C; Kauwe JSK
    Neurology; 2019 Apr; 92(15):e1745-e1753. PubMed ID: 30867271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based family history-specific risks for colorectal cancer: a constellation approach.
    Taylor DP; Burt RW; Williams MS; Haug PJ; Cannon-Albright LA
    Gastroenterology; 2010 Mar; 138(3):877-85. PubMed ID: 19932107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer incidence and survival in relation to prostate cancer as second cancer in relatives.
    Zheng G; Sundquist J; Sundquist K; Ji J
    Cancer Med; 2022 May; 11(10):2117-2124. PubMed ID: 35312170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of breast cancer in families of multiple affected women and men.
    Bevier M; Sundquist K; Hemminki K
    Breast Cancer Res Treat; 2012 Apr; 132(2):723-8. PubMed ID: 22179927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and meta-analysis of familial prostate cancer risk.
    Johns LE; Houlston RS
    BJU Int; 2003 Jun; 91(9):789-94. PubMed ID: 12780833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial risk of lung carcinoma in the Icelandic population.
    Jonsson S; Thorsteinsdottir U; Gudbjartsson DF; Jonsson HH; Kristjansson K; Arnason S; Gudnason V; Isaksson HJ; Hallgrimsson J; Gulcher JR; Amundadottir LT; Kong A; Stefansson K
    JAMA; 2004 Dec; 292(24):2977-83. PubMed ID: 15613665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cancer in relatives of prostate cancer probands.
    Isaacs SD; Kiemeney LA; Baffoe-Bonnie A; Beaty TH; Walsh PC
    J Natl Cancer Inst; 1995 Jul; 87(13):991-6. PubMed ID: 7629886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
    Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
    Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma.
    McWilliams RR; Rabe KG; Olswold C; De Andrade M; Petersen GM
    Cancer; 2005 Jul; 104(2):388-94. PubMed ID: 15912495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based description of familial clustering of Chiari malformation Type I.
    Abbott D; Brockmeyer D; Neklason DW; Teerlink C; Cannon-Albright LA
    J Neurosurg; 2018 Feb; 128(2):460-465. PubMed ID: 28156254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial risk of prostate cancer in Iceland.
    Eldon BJ; Jonsson E; Tomasson J; Tryggvadottir L; Tulinius H
    BJU Int; 2003 Dec; 92(9):915-9. PubMed ID: 14632846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.
    Beebe-Dimmer JL; Kapron AL; Fraser AM; Smith KR; Cooney KA
    J Clin Oncol; 2020 Jun; 38(16):1807-1813. PubMed ID: 32208047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis.
    Bruner DW; Moore D; Parlanti A; Dorgan J; Engstrom P
    Int J Cancer; 2003 Dec; 107(5):797-803. PubMed ID: 14566830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.
    Tutera AM; Sellers TA; Potter JD; Drinkard CR; Wiesner GL; Folsom AR
    Genet Epidemiol; 1996; 13(2):207-21. PubMed ID: 8722747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.